// LBF Funded Research Projects (2012–2025)

export const researchData = [
  {
    id: "2012-project-1",
    year: 2012,
    title: "Human Proteome Atlas Labeling",
    impact: "Advanced understanding of pediatric brain tumor protein profiles through proteomic analysis.",
    money: "$50,000",
    summary:
      "This project at the Brain Tumor Institute at Children's National Hospital supported the Human Proteome Atlas SILAC Project. Funding covered equipment, reagents, and a physician scientist stipend to study protein roles in pediatric brain tumors using mass spectrometry.",
  },
  {
    id: "2013-2015-project-1",
    year: 2015,
    title: "Brain Tumor Institute Support and Equipment Funding",
    impact: "Enhanced laboratory infrastructure and research capacity for pediatric brain tumor studies.",
    money: "$261,000",
    summary:
      "Between 2013–2015, multiple grants supported the Brain Tumor Institute at Children's National Hospital. Funds went toward equipment such as an HPLC unit, CellDrop counter, freezer units, and researcher salaries to advance pediatric brain cancer research.",
  },
  {
    id: "2016-project-1",
    year: 2016,
    title: "Liquid Biopsy: Detecting Tumor Fingerprints in Cerebrospinal Fluid",
    impact: "Pioneered cerebrospinal fluid–based biomarker detection for pediatric brain tumors.",
    money: "$143,000",
    summary:
      "This grant supported three research projects in the labs of Drs. Brian Rood and Javad Nazarian at Children's National Hospital, focusing on protein biomarker screening, targeted pathway alteration, and translational research in DIPG.",
  },
  {
    id: "2016-project-2",
    year: 2016,
    title: "Protein Biomarkers in the Cerebrospinal Fluid",
    impact: "Integrated proteomic and genomic sequencing to identify novel tumor-specific fusions.",
    money: "$70,000",
    summary:
      "Led by Dr. Brian Rood, this project created a tumor-specific protein database to map all proteins sequenced in medulloblastoma, enabling new therapeutic target identification and early detection markers.",
  },
  {
    id: "2018-project-1",
    year: 2018,
    title: "Proteogenomics in Low Grade Gliomas",
    impact: "Delivered high-resolution proteogenomic data to uncover novel LGG peptide biomarkers.",
    money: "$150,000",
    summary:
      "This project in Dr. Rood's lab advanced research on low-grade gliomas, generating spectral data and identifying LGG-specific peptides to activate immune responses. Data was shared publicly through CAVATICA/CBTTC/Kids First.",
  },
  {
    id: "2020-project-1",
    year: 2020,
    title: "Discovering Unique Tumor Proteins in Cerebrospinal Fluid",
    impact: "Enabled early, personalized detection of brain tumor recurrence using protein fragments.",
    money: "$143,000",
    summary:
      "Supported development of tumor-specific peptide biomarkers to customize therapy and monitor recurrence in children with brain tumors at Children's National Hospital.",
  },
  {
    id: "2020-project-2",
    year: 2020,
    title: "Clinical Trial: Combination Therapy in Refractory Gliomas",
    impact: "Launched national Phase I trial for resistant pediatric gliomas using dual-drug therapy.",
    money: "$225,000",
    summary:
      "LBF supported a PNOC-led Phase I trial combining trametinib and everolimus to treat resistant gliomas in children, led by Dr. Lindsay Kilburn at Children's National Hospital.",
  },
  {
    id: "2021-project-1",
    year: 2021,
    title: "Project Accelerate @ Children's Brain Tumor Network (CBTN)",
    impact: "Accelerated data sharing and research collaboration with 7,000+ samples and 400+ projects.",
    money: "$675,000",
    summary:
      "A 3-year grant supporting translational pediatric brain tumor research through Project Accelerate, providing molecular, imaging, and clinical data for AI-driven discoveries.",
  },
  {
    id: "2022-project-1",
    year: 2022,
    title: "DMG/DIPG Research Lab Manager @ Children's National Hospital",
    impact: "Enabled new clinical trials and attracted $8M in additional funding for the Nazarian Lab.",
    money: "$460,000",
    summary:
      "This 3-year grant supported lab management infrastructure to advance DIPG and DMG research, directly leading to three new clinical trials and major funding growth.",
  },
  {
    id: "2023-project-1",
    year: 2023,
    title: "Liquid Biopsy Fund @ Children's National Hospital",
    impact: "Developed new liquid biopsy diagnostics to measure tumor burden in children's brains.",
    money: "$300,000",
    summary:
      "A 3-year initiative to refine liquid biopsy technology, allowing doctors to detect trace tumor cells and guide treatment intensity for children with brain tumors.",
  },
  {
    id: "2023-project-2",
    year: 2023,
    title: "Translational Imaging Acquisition for Medulloblastoma",
    impact: "Expanded global imaging data for medulloblastoma research.",
    money: "$40,000",
    summary:
      "This grant supported integration of imaging and clinical data in the CBTN database to aid global researchers, honoring LBF Hero Kasey Zachmann.",
  },
  {
    id: "2023-project-3",
    year: 2023,
    title: "Advancing Preclinical Research for Diffuse Hemispheric Glioma (DHG)",
    impact: "Developed new preclinical DHG models to accelerate drug discovery.",
    money: "$50,000",
    summary:
      "Supported the creation of cell-line-based models for DHG, a recently identified pediatric high-grade glioma subtype, honoring LBF Hero Max Pound.",
  },
  {
    id: "2023-project-4",
    year: 2023,
    title: "Translation of Clinical Trial Documents for CBTN and PNOC",
    impact: "Improved accessibility for international trial participants through document translation.",
    money: "$10,000",
    summary:
      "Funded translation of patient consent forms and clinical materials to broaden inclusivity in pediatric neuro-oncology trials, honoring LBF Hero Maddie Highfill.",
  },
  {
    id: "2024-project-1",
    year: 2024,
    title: "Neonatal Ependymoma Injection Pilot Experiment",
    impact: "Developed improved pre-clinical models using neonatal mice with intact immune systems.",
    money: "$135,000",
    summary:
      "Led by Dr. Brian Rood, this pilot creates immune-competent mouse models to better study tumor-immune interactions in ependymoma. In honor of LBF Hero Cameron.",
  },
  {
    id: "2024-project-2",
    year: 2024,
    title: "Comprehensive Data Integration and AI @ CBTN",
    impact: "Enhanced AI pipeline and data harmonization for pediatric brain tumor research.",
    money: "$500,000",
    summary:
      "A 2-year CBTN grant focusing on integrating multi-modal data and refining AI-driven insights for pediatric brain tumor research.",
  },
  {
    id: "2024-project-3",
    year: 2024,
    title: "Expansion of CBTN Organoid Program",
    impact: "Accelerated drug testing with 3D tumor organoids across major research sites.",
    money: "$75,000",
    summary:
      "This investment expands organoid-based research at Michigan Medicine, UCSF, and CHOP, allowing real-time drug testing and targeted therapy development.",
  },
  {
    id: "2024-project-4",
    year: 2024,
    title: "CAR T-Cell and Focused Ultrasound Therapy for Ependymoma",
    impact: "Advanced preclinical immunotherapy approach for pediatric ependymoma.",
    money: "$179,000",
    summary:
      "Led by Dr. Dalia Haydar, this project combines CAR T-cell therapy with low-frequency focused ultrasound to overcome immune suppression and the blood-brain barrier.",
  },
  {
    id: "2024-project-5",
    year: 2024,
    title: "PNOC027 Trial for Ependymoma Expansion",
    impact: "Enabled clinical trial expansion to include relapsed ependymoma patients.",
    money: "N/A",
    summary:
      "LBF provided additional funding to finalize the PNOC027 clinical trial, which uses real-time drug screening and genomic testing to tailor treatments for relapsed ependymoma.",
  },
  {
    id: "2025-project-1",
    year: 2025,
    title: "PNOC044 – Thyroid Hormone Therapy for Relapsed Medulloblastoma",
    impact: "Launched first hormone-based therapy trial for relapsed pediatric medulloblastoma.",
    money: "$340,000",
    summary:
      "This PNOC trial tests T3 hormone therapy in combination with chemotherapy to treat relapsed medulloblastoma, with potential for rapid clinical adoption due to existing FDA approval.",
  },
  {
    id: "2025-project-2",
    year: 2025,
    title: "PNOC041 – Metformin Therapy for Pediatric PFA Ependymoma",
    impact: "Began first clinical trial testing metformin as a potential therapy for PFA ependymoma.",
    money: "$200,000",
    summary:
      "This international PNOC trial evaluates the anti-tumor effects of metformin in children with recurrent PFA ependymoma, aiming to introduce a safe, low-cost therapeutic option.",
  },
  {
    id: "2025-project-3",
    year: 2025,
    title: "Tumoroid-Based Drug Screening for Low-Grade Glioma",
    impact: "Established one of the largest LGG tumoroid collections for drug discovery.",
    money: "$250,000",
    summary:
      "This project uses 3D tumoroid models to identify effective and less toxic drug combinations for pediatric low-grade glioma, advancing safer and personalized therapies.",
  },
];

